The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.

from NYT > Health https://ift.tt/3vlVFdY

Related Posts:

0 comments:

Post a Comment

Popular Posts